T-CELL LEUKEMIA
Clinical trials for T-CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for T-CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered T-Cells take aim at Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-phase study tests a new treatment called CD4CAR for people with T-cell leukemia or lymphoma that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, modified in a lab to target and attack cancer cells. The main goal is t…
Matched conditions: T-CELL LEUKEMIA
Phase: PHASE1 • Sponsor: Huda Salman • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Leukemia prevention trial targets High-Risk virus carriers
Prevention Recruiting nowThis study tests whether the drug mogamulizumab can prevent adult T-cell leukemia/lymphoma (ATL) in people infected with HTLV-1 who have early cell changes. About 134 participants will receive a limited course of the drug to reduce their viral load. The goal is to stop cancer bef…
Matched conditions: T-CELL LEUKEMIA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated May 13, 2026 16:03 UTC
-
Rare leukemia study aims to unlock secrets of T-PLL
Knowledge-focused Recruiting nowThis study gathers information from 50 people with a rare and aggressive blood cancer called T-cell prolymphocytic leukemia (T-PLL). Researchers will look at patients' medical records, lab results, and genetic data to better understand the disease and how it responds to current t…
Matched conditions: T-CELL LEUKEMIA
Sponsor: French Innovative Leukemia Organisation • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC